ARCUTIS BIOTHERAPEUTICS INC COM is a security (CUSIP 03969K108) tracked across SEC portfolio filings. 264 institutional managers reported $3.1B on Form 13F as of 2026-06-30; 29 registered fund positions totaling $145.1M via N-PORT as of 2026-05-31.
Showing 15 of 264 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | New York, NY | $290.4M | 12,327,000 |
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $232.6M | 9,874,511 |
| BlackRock, Inc. | New York, NY | $216.8M | 9,200,411 |
| VANGUARD GROUP INC | Valley Forge, PA | $210.7M | 7,253,936 |
| Rubric Capital Management LP | New York, NY | $194.9M | 8,271,577 |
| STATE STREET CORP | BOSTON, MA | $148.3M | 6,296,197 |
| Polar Capital Holdings Plc | London, X0 | $133.5M | 5,666,940 |
| JENNISON ASSOCIATES LLC | NEW YORK, NY | $110.6M | 4,219,058 |
| GILDER GAGNON HOWE & CO LLC | New York, NY | $101.4M | 4,304,010 |
| MORGAN STANLEY | NEW YORK, NY | $99.4M | 4,218,931 |
| UBS Group AG | Zurich, V8 | $78.4M | 3,329,224 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $71.8M | 3,045,306 |
| D. E. Shaw & Co., Inc. | New York, NY | $58.8M | 2,496,222 |
| MARSHALL WACE, LLP | LONDON, X0 | $57.3M | 2,431,778 |
| FRANKLIN RESOURCES INC | San Mateo, CA | $54.1M | 2,297,943 |
Showing 15 of 29 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| PGIM Jennison Small Company Fund | Prudential Jennison Small Co Fund, Inc. | $41.0M | 128.72% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $29.3M | 3.59% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $13.0M | 5.99% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $12.1M | 6.92% |
| PGIM Jennison Health Sciences Fund | Prudential Sector Funds, Inc. | $8.4M | 60.50% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $7.1M | 62.66% |
| VANGUARD STRATEGIC EQUITY FUND | VANGUARD HORIZON FUNDS | $4.4M | 4.36% |
| Virtus Zevenbergen Innovative Growth Stock Fund | Virtus Asset Trust | $4.2M | 123.45% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $4.1M | 8.59% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $3.4M | 60.62% |
| Optimum Small-Mid Cap Growth Fund | Optimum Fund Trust | $2.3M | 30.71% |
| PGIM Jennison Blend Fund | Prudential Jennison Blend Fund, Inc. | $2.1M | 17.66% |
| abrdn U.S. Small Cap Equity Fund | abrdn Funds | $1.7M | 46.33% |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | Goldman Sachs ETF Trust | $1.6M | 16.20% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $1.4M | 0.25% |